- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
According to our latest study, the global Drug Repositioning market size was valued at USD 27030 million in 2022 and is forecast to a readjusted size of USD 36780 million by 2029 with a CAGR of 4.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Drug Repositioning key players include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, etc. Global top five manufacturers hold a share about 15%.
North America is the largest market, with a share about 40%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Generic Drugs is the largest segment, with a share about 65%. And in terms of application, the largest application is Cancer, followed by Cardiovascular Diseases.
This report is a detailed and comprehensive analysis for global Drug Repositioning market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Drug Repositioning market size and forecasts, in consumption value ($ Million), 2018-2029
Global Drug Repositioning market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Drug Repositioning market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Drug Repositioning market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug Repositioning
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug Repositioning market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Novartis, Mylan, Johnson & Johnson and Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Drug Repositioning market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Generic Drugs
Clinical Trial Failed Drugs
Market segment by Application
Cardiovascular Diseases
Mental Illness
Cancer
Others
Market segment by players, this report covers
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drug Repositioning product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Repositioning, with revenue, gross margin and global market share of Drug Repositioning from 2018 to 2023.
Chapter 3, the Drug Repositioning competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Drug Repositioning market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Repositioning.
Chapter 13, to describe Drug Repositioning research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Drug Repositioning
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Drug Repositioning by Type
1.3.1 Overview: Global Drug Repositioning Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Drug Repositioning Consumption Value Market Share by Type in 2022
1.3.3 Generic Drugs
1.3.4 Clinical Trial Failed Drugs
1.4 Global Drug Repositioning Market by Application
1.4.1 Overview: Global Drug Repositioning Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cardiovascular Diseases
1.4.3 Mental Illness
1.4.4 Cancer
1.4.5 Others
1.5 Global Drug Repositioning Market Size & Forecast
1.6 Global Drug Repositioning Market Size and Forecast by Region
1.6.1 Global Drug Repositioning Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Drug Repositioning Market Size by Region, (2018-2029)
1.6.3 North America Drug Repositioning Market Size and Prospect (2018-2029)
1.6.4 Europe Drug Repositioning Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Drug Repositioning Market Size and Prospect (2018-2029)
1.6.6 South America Drug Repositioning Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Drug Repositioning Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Drug Repositioning Product and Solutions
2.1.4 Teva Drug Repositioning Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Teva Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Drug Repositioning Product and Solutions
2.2.4 Novartis Drug Repositioning Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Drug Repositioning Product and Solutions
2.3.4 Mylan Drug Repositioning Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Mylan Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Drug Repositioning Product and Solutions
2.4.4 Johnson & Johnson Drug Repositioning Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Drug Repositioning Product and Solutions
2.5.4 Pfizer Drug Repositioning Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Bausch Health
2.6.1 Bausch Health Details
2.6.2 Bausch Health Major Business
2.6.3 Bausch Health Drug Repositioning Product and Solutions
2.6.4 Bausch Health Drug Repositioning Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bausch Health Recent Developments and Future Plans
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Drug Repositioning Product and Solutions
2.7.4 GSK Drug Repositioning Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GSK Recent Developments and Future Plans
2.8 ChemRar Group
2.8.1 ChemRar Group Details
2.8.2 ChemRar Group Major Business
2.8.3 ChemRar Group Drug Repositioning Product and Solutions
2.8.4 ChemRar Group Drug Repositioning Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 ChemRar Group Recent Developments and Future Plans
2.9 Glenmark
2.9.1 Glenmark Details
2.9.2 Glenmark Major Business
2.9.3 Glenmark Drug Repositioning Product and Solutions
2.9.4 Glenmark Drug Repositioning Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Glenmark Recent Developments and Future Plans
2.10 Fujifilm
2.10.1 Fujifilm Details
2.10.2 Fujifilm Major Business
2.10.3 Fujifilm Drug Repositioning Product and Solutions
2.10.4 Fujifilm Drug Repositioning Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Fujifilm Recent Developments and Future Plans
2.11 Dr. Reddy
2.11.1 Dr. Reddy Details
2.11.2 Dr. Reddy Major Business
2.11.3 Dr. Reddy Drug Repositioning Product and Solutions
2.11.4 Dr. Reddy Drug Repositioning Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Dr. Reddy Recent Developments and Future Plans
2.12 R-Pharma
2.12.1 R-Pharma Details
2.12.2 R-Pharma Major Business
2.12.3 R-Pharma Drug Repositioning Product and Solutions
2.12.4 R-Pharma Drug Repositioning Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 R-Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Drug Repositioning Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Drug Repositioning by Company Revenue
3.2.2 Top 3 Drug Repositioning Players Market Share in 2022
3.2.3 Top 6 Drug Repositioning Players Market Share in 2022
3.3 Drug Repositioning Market: Overall Company Footprint Analysis
3.3.1 Drug Repositioning Market: Region Footprint
3.3.2 Drug Repositioning Market: Company Product Type Footprint
3.3.3 Drug Repositioning Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Drug Repositioning Consumption Value and Market Share by Type (2018-2023)
4.2 Global Drug Repositioning Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Drug Repositioning Consumption Value Market Share by Application (2018-2023)
5.2 Global Drug Repositioning Market Forecast by Application (2024-2029)
6 North America
6.1 North America Drug Repositioning Consumption Value by Type (2018-2029)
6.2 North America Drug Repositioning Consumption Value by Application (2018-2029)
6.3 North America Drug Repositioning Market Size by Country
6.3.1 North America Drug Repositioning Consumption Value by Country (2018-2029)
6.3.2 United States Drug Repositioning Market Size and Forecast (2018-2029)
6.3.3 Canada Drug Repositioning Market Size and Forecast (2018-2029)
6.3.4 Mexico Drug Repositioning Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Drug Repositioning Consumption Value by Type (2018-2029)
7.2 Europe Drug Repositioning Consumption Value by Application (2018-2029)
7.3 Europe Drug Repositioning Market Size by Country
7.3.1 Europe Drug Repositioning Consumption Value by Country (2018-2029)
7.3.2 Germany Drug Repositioning Market Size and Forecast (2018-2029)
7.3.3 France Drug Repositioning Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Drug Repositioning Market Size and Forecast (2018-2029)
7.3.5 Russia Drug Repositioning Market Size and Forecast (2018-2029)
7.3.6 Italy Drug Repositioning Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Drug Repositioning Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Drug Repositioning Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Drug Repositioning Market Size by Region
8.3.1 Asia-Pacific Drug Repositioning Consumption Value by Region (2018-2029)
8.3.2 China Drug Repositioning Market Size and Forecast (2018-2029)
8.3.3 Japan Drug Repositioning Market Size and Forecast (2018-2029)
8.3.4 South Korea Drug Repositioning Market Size and Forecast (2018-2029)
8.3.5 India Drug Repositioning Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Drug Repositioning Market Size and Forecast (2018-2029)
8.3.7 Australia Drug Repositioning Market Size and Forecast (2018-2029)
9 South America
9.1 South America Drug Repositioning Consumption Value by Type (2018-2029)
9.2 South America Drug Repositioning Consumption Value by Application (2018-2029)
9.3 South America Drug Repositioning Market Size by Country
9.3.1 South America Drug Repositioning Consumption Value by Country (2018-2029)
9.3.2 Brazil Drug Repositioning Market Size and Forecast (2018-2029)
9.3.3 Argentina Drug Repositioning Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Drug Repositioning Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Drug Repositioning Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Drug Repositioning Market Size by Country
10.3.1 Middle East & Africa Drug Repositioning Consumption Value by Country (2018-2029)
10.3.2 Turkey Drug Repositioning Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Drug Repositioning Market Size and Forecast (2018-2029)
10.3.4 UAE Drug Repositioning Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Drug Repositioning Market Drivers
11.2 Drug Repositioning Market Restraints
11.3 Drug Repositioning Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Drug Repositioning Industry Chain
12.2 Drug Repositioning Upstream Analysis
12.3 Drug Repositioning Midstream Analysis
12.4 Drug Repositioning Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Drug Repositioning Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Drug Repositioning Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Drug Repositioning Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Drug Repositioning Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Teva Company Information, Head Office, and Major Competitors
Table 6. Teva Major Business
Table 7. Teva Drug Repositioning Product and Solutions
Table 8. Teva Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Teva Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Drug Repositioning Product and Solutions
Table 13. Novartis Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Mylan Company Information, Head Office, and Major Competitors
Table 16. Mylan Major Business
Table 17. Mylan Drug Repositioning Product and Solutions
Table 18. Mylan Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Mylan Recent Developments and Future Plans
Table 20. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 21. Johnson & Johnson Major Business
Table 22. Johnson & Johnson Drug Repositioning Product and Solutions
Table 23. Johnson & Johnson Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Johnson & Johnson Recent Developments and Future Plans
Table 25. Pfizer Company Information, Head Office, and Major Competitors
Table 26. Pfizer Major Business
Table 27. Pfizer Drug Repositioning Product and Solutions
Table 28. Pfizer Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Pfizer Recent Developments and Future Plans
Table 30. Bausch Health Company Information, Head Office, and Major Competitors
Table 31. Bausch Health Major Business
Table 32. Bausch Health Drug Repositioning Product and Solutions
Table 33. Bausch Health Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bausch Health Recent Developments and Future Plans
Table 35. GSK Company Information, Head Office, and Major Competitors
Table 36. GSK Major Business
Table 37. GSK Drug Repositioning Product and Solutions
Table 38. GSK Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. GSK Recent Developments and Future Plans
Table 40. ChemRar Group Company Information, Head Office, and Major Competitors
Table 41. ChemRar Group Major Business
Table 42. ChemRar Group Drug Repositioning Product and Solutions
Table 43. ChemRar Group Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. ChemRar Group Recent Developments and Future Plans
Table 45. Glenmark Company Information, Head Office, and Major Competitors
Table 46. Glenmark Major Business
Table 47. Glenmark Drug Repositioning Product and Solutions
Table 48. Glenmark Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Glenmark Recent Developments and Future Plans
Table 50. Fujifilm Company Information, Head Office, and Major Competitors
Table 51. Fujifilm Major Business
Table 52. Fujifilm Drug Repositioning Product and Solutions
Table 53. Fujifilm Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Fujifilm Recent Developments and Future Plans
Table 55. Dr. Reddy Company Information, Head Office, and Major Competitors
Table 56. Dr. Reddy Major Business
Table 57. Dr. Reddy Drug Repositioning Product and Solutions
Table 58. Dr. Reddy Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Dr. Reddy Recent Developments and Future Plans
Table 60. R-Pharma Company Information, Head Office, and Major Competitors
Table 61. R-Pharma Major Business
Table 62. R-Pharma Drug Repositioning Product and Solutions
Table 63. R-Pharma Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. R-Pharma Recent Developments and Future Plans
Table 65. Global Drug Repositioning Revenue (USD Million) by Players (2018-2023)
Table 66. Global Drug Repositioning Revenue Share by Players (2018-2023)
Table 67. Breakdown of Drug Repositioning by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Drug Repositioning, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Drug Repositioning Players
Table 70. Drug Repositioning Market: Company Product Type Footprint
Table 71. Drug Repositioning Market: Company Product Application Footprint
Table 72. Drug Repositioning New Market Entrants and Barriers to Market Entry
Table 73. Drug Repositioning Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Drug Repositioning Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Drug Repositioning Consumption Value Share by Type (2018-2023)
Table 76. Global Drug Repositioning Consumption Value Forecast by Type (2024-2029)
Table 77. Global Drug Repositioning Consumption Value by Application (2018-2023)
Table 78. Global Drug Repositioning Consumption Value Forecast by Application (2024-2029)
Table 79. North America Drug Repositioning Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Drug Repositioning Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Drug Repositioning Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Drug Repositioning Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Drug Repositioning Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Drug Repositioning Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Drug Repositioning Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Drug Repositioning Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Drug Repositioning Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Drug Repositioning Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Drug Repositioning Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Drug Repositioning Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Drug Repositioning Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Drug Repositioning Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Drug Repositioning Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Drug Repositioning Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Drug Repositioning Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Drug Repositioning Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Drug Repositioning Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Drug Repositioning Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Drug Repositioning Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Drug Repositioning Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Drug Repositioning Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Drug Repositioning Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Drug Repositioning Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Drug Repositioning Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Drug Repositioning Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Drug Repositioning Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Drug Repositioning Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Drug Repositioning Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Drug Repositioning Raw Material
Table 110. Key Suppliers of Drug Repositioning Raw Materials
List of Figures
Figure 1. Drug Repositioning Picture
Figure 2. Global Drug Repositioning Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Drug Repositioning Consumption Value Market Share by Type in 2022
Figure 4. Generic Drugs
Figure 5. Clinical Trial Failed Drugs
Figure 6. Global Drug Repositioning Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Drug Repositioning Consumption Value Market Share by Application in 2022
Figure 8. Cardiovascular Diseases Picture
Figure 9. Mental Illness Picture
Figure 10. Cancer Picture
Figure 11. Others Picture
Figure 12. Global Drug Repositioning Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Drug Repositioning Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Drug Repositioning Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Drug Repositioning Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Drug Repositioning Consumption Value Market Share by Region in 2022
Figure 17. North America Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Drug Repositioning Revenue Share by Players in 2022
Figure 23. Drug Repositioning Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Drug Repositioning Market Share in 2022
Figure 25. Global Top 6 Players Drug Repositioning Market Share in 2022
Figure 26. Global Drug Repositioning Consumption Value Share by Type (2018-2023)
Figure 27. Global Drug Repositioning Market Share Forecast by Type (2024-2029)
Figure 28. Global Drug Repositioning Consumption Value Share by Application (2018-2023)
Figure 29. Global Drug Repositioning Market Share Forecast by Application (2024-2029)
Figure 30. North America Drug Repositioning Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Drug Repositioning Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Drug Repositioning Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Drug Repositioning Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Drug Repositioning Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Drug Repositioning Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 40. France Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Drug Repositioning Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Drug Repositioning Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Drug Repositioning Consumption Value Market Share by Region (2018-2029)
Figure 47. China Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 50. India Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Drug Repositioning Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Drug Repositioning Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Drug Repositioning Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Drug Repositioning Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Drug Repositioning Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Drug Repositioning Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Drug Repositioning Consumption Value (2018-2029) & (USD Million)
Figure 64. Drug Repositioning Market Drivers
Figure 65. Drug Repositioning Market Restraints
Figure 66. Drug Repositioning Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Drug Repositioning in 2022
Figure 69. Manufacturing Process Analysis of Drug Repositioning
Figure 70. Drug Repositioning Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
